Analysis of the role of epidermal cytokines in skin inflammation
表皮细胞因子在皮肤炎症中的作用分析
基本信息
- 批准号:63480246
- 负责人:
- 金额:$ 2.75万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for General Scientific Research (B)
- 财政年份:1988
- 资助国家:日本
- 起止时间:1988 至 1989
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have developed a method to detect messenger RNA (mRNA) expression of keratinocytes in situ in the study performed in the previous year. We have applied this technique to examine the role of interleukins in psoriasis, one of typical epidermal proliferating diseases, this year.Biopsied specimens were obtained from 27 patients with psoriasis vulgaris and 9 healthy volunteers after informed consent. They were snap-frozen in liquid nitrogen and 10 mu thick sections were prepared. The sections were fixed with 4% paraformaldehyde and ethanol, and hybridized with biotin labeled complementary DNA (cDNA) of interleukin (IL) -1, IL-6 and IL-6 receptor (IL-6R). They were treated with avidin alkaline phosphatase and its enzyme substrates.IL-1 message was expressed by healthy skin, uninvolved skin of psoriasis and transitional zone between uninvolved and fully developed psoriatic lesion but not in psoriatic lesion. The message of IL-6 was detected in the uninvolved, transitional zone and psoriatic lesion but not in healthy skin. It was expressed more strongly in transitional zone and tended to fade in psoriatic lesion. IL-6R message was found in uninvolved and transitional zone but not in psoriatic lesion and healthy skin.Thus synthesis of IL-6 and its receptor was regulated in the psoriatic skin by certain factors to suppress excess proliferation as is found in neoplasmas. IL-6 and its receptor expression by psoriatic skin play an important role in pathogenesis of psoriasis.
在前一年的研究中,我们开发了一种原位检测角质形成细胞信使RNA(MRNA)表达的方法。今年,我们应用这项技术检测了白介素性银屑病在银屑病中的作用,这是一种典型的表皮增生性疾病。将它们在液氮中快速冷冻,制备10亩厚的切片。切片用4%多聚甲醛和乙醇固定,与生物素标记的白介素1、白介素6和白介素6受体的互补DNA杂交。IL-1在正常皮肤、银屑病非皮损皮肤和银屑病皮损与完全皮损之间的过渡区表达,但在银屑病皮损中不表达。在正常皮肤、移行区和银屑病皮损中检测到IL-6的表达,而在正常皮肤中未检测到。在移行区表达较强,在银屑病皮损中表达减弱。IL-6R在非皮损区和移行区表达,但在银屑病皮损和正常皮肤中不表达,因此,银屑病患者皮肤中IL-6及其受体的合成受某些因子的调节,从而抑制过度增殖,与肿瘤一样。银屑病患者皮肤中IL-6及其受体的表达在银屑病发病机制中起重要作用。
项目成果
期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
K.Nishioka,;I.Katayama,;H.ETO,;Y.Sato,;T.Funato,: Dermatologica. 1989.
K.Nishioka,;I.Katayama,;H.ETO,;Y.Sato,;T.Funato,:皮肤病学。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishioka K, Funato T, Sato Y, Eto H, Katayama I and Nishiyama S: "Production of interleukin 1 alpha by a trichilemmoma cell line." Journal of Dermatology 1990.
Nishioka K、Funato T、Sato Y、Eto H、Katayama I 和 Nishiyama S:“毛毛虫瘤细胞系产生白细胞介素 1 α”。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishioka k,katayama I,ETo,H,Funato T: "Trichilemmona cell live can qeuevate interleukin 1 alpha" Dermatologica. 179. 135-176 (1989)
Nishioka k,katayama I,ETo,H,Funato T:“Trichilemmona 细胞活体可以使白细胞介素 1 α 升高”Dermatologica。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishioka K,Funato T,Sato Y,Eto H,Katayama I,Nishiyama S.: "Production of interleukin 1 alpha by a trichilemmoma cell line" Journal of Dermatology. (1990)
Nishioka K、Funato T、Sato Y、Eto H、Katayama I、Nishiyama S.:“毛毛虫瘤细胞系产生白细胞介素 1 α”皮肤病学杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nishioka K,Funato T,Sato Y,Ohta Y.Eto H.Katayama I,Nishiyama S: "Droduction of interleukin 1 alpha by a trichilemmoma cell live" Journal of Deymatocepy(印刷中). (1990)
Nishioka K、Funato T、Sato Y、Ohta Y. Eto H. Katayama I、Nishiyama S:“毛毛虫细胞活体产生白介素 1 α”Journal of Deymatocepy(出版中)(1990 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NISHIOKA Kiyoshi其他文献
NISHIOKA Kiyoshi的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NISHIOKA Kiyoshi', 18)}}的其他基金
Mechanism of the Development of Skin Sclerosis in Scleroderma
硬皮病皮肤硬化的发生机制
- 批准号:
12470176 - 财政年份:2000
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Analysis of Langerhans cell chemotactic factors
朗格汉斯细胞趋化因子分析
- 批准号:
07457189 - 财政年份:1996
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似国自然基金
环形RNA在银屑病(psoriasis)干预治疗中的分子机制及潜在应用
- 批准号:32371349
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Application of artificial intelligence to predict biologic systemic therapy clinical response, effectiveness and adverse events in psoriasis
应用人工智能预测生物系统治疗银屑病的临床反应、有效性和不良事件
- 批准号:
MR/Y009657/1 - 财政年份:2024
- 资助金额:
$ 2.75万 - 项目类别:
Fellowship
Investigating the efficacy and safety profiles of Bimekizumab in treating moderate-to-severe plaque psoriasis: A Canadian retrospective study
调查 Bimekizumab 治疗中重度斑块状银屑病的疗效和安全性:加拿大回顾性研究
- 批准号:
484723 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Studentship Programs
Tissue-Anchored vs. Circulating Engineered Enzyme Constructs for Immunometabolic Resolution of Psoriasis
组织锚定与循环工程酶构建体用于银屑病免疫代谢解决
- 批准号:
10667165 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
A First-in-class Topical Immunoregulatory Therapeutic for Psoriasis
一流的牛皮癣局部免疫调节疗法
- 批准号:
10820331 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Integrative and trans-ethnic study to understand psoriasis associated signals
了解银屑病相关信号的综合和跨种族研究
- 批准号:
10657973 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Identification of TARC-producing cells in pustular psoriasis and elucidation of pathogenesis
脓疱型银屑病中 TARC 产生细胞的鉴定及发病机制的阐明
- 批准号:
23K07794 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel supersulfide delivery system for the treatment of psoriasis
一种用于治疗牛皮癣的新型超硫化物递送系统
- 批准号:
23K17215 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of Novel Topical Therapeutics for Psoriasis
牛皮癣新型局部治疗药物的开发
- 批准号:
10698601 - 财政年份:2023
- 资助金额:
$ 2.75万 - 项目类别:
An investigation of circadian rhythms in psoriasis skin and time-of-day dependent response to ultraviolet B radiation
银屑病皮肤昼夜节律和对紫外线 B 辐射的时间依赖性反应的研究
- 批准号:
MR/W02523X/1 - 财政年份:2022
- 资助金额:
$ 2.75万 - 项目类别:
Fellowship